Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Chidamide Plus DCAG for Relapsed/Refractory AML
ClinicalTrials.gov study NCT02886559. IPD Sharing: YES. Countries: 1. Publications: 1.
10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1
ClinicalTrials.gov study NCT02252107. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients
ClinicalTrials.gov study NCT02863302. IPD Sharing: NO. Countries: 1. Publications: 2.
Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CR
ClinicalTrials.gov study NCT01246752. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00915252. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
ClinicalTrials.gov study NCT01159028. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Timed-Sequential Induction in CBF-AML
ClinicalTrials.gov study NCT00428558. IPD Sharing: Not stated. Countries: 1. Publications: 4.
"InDACtion" vs "3+7" Induction in AML
ClinicalTrials.gov study NCT02172872. IPD Sharing: Not stated. Countries: 9. Publications: 2.
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
ClinicalTrials.gov study NCT06262438. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)
ClinicalTrials.gov study NCT00422890. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing All
ClinicalTrials.gov study NCT01746147. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML
ClinicalTrials.gov study NCT01191957. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML
ClinicalTrials.gov study NCT02662647. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01242774. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
ClinicalTrials.gov study NCT04310592. IPD Sharing: NO. Countries: 1. Publications: 2.
Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
ClinicalTrials.gov study NCT02474290. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Ascorbic Acid Levels in MDS, AML, and CMML Patients
ClinicalTrials.gov study NCT03526666. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML
ClinicalTrials.gov study NCT03620955. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
ClinicalTrials.gov study NCT00538876. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)
ClinicalTrials.gov study NCT01146262. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.